Prevalence of Themes Linked to Delayed Presentation of Breast Cancer in Africa: A Meta-Analysis of Patient-Reported Studies.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
05 2020
Historique:
entrez: 22 5 2020
pubmed: 22 5 2020
medline: 29 7 2021
Statut: ppublish

Résumé

The prevalence of themes linked to delay in presentation of breast cancer (BC) and their underlying factors vary considerably throughout Africa. Regional differences and trends are largely unreported. The purpose of this research was to provide summary estimates of the prevalence and distribution of the themes and underlying factors linked to delay in the presentation of BC, regional variation, and trends in an effort to identify targets for intervention. We screened articles found through PubMed/Medline, African Journal OnLine, Science Direct, Google/Google Scholar, and ResearchGate. We included patient-reported surveys on the reasons linked to delayed presentation under 6 previously identified themes: symptom misinterpretation, fear, preference for alternative care, social influence, hospital-related factors, and access factors. The meta-analytical procedure in MetaXL used the quality-effect model. Twelve of the 236 identified articles were eligible for this review. The overall summary estimate of late presentation (> 90 days) was 54% (95% CI, 23 to 85) and was worst in the eastern and central regions. Symptom misinterpretation was the most common theme (50%; 95% CI, 21 to 56), followed by fear (17%; 95% CI, 3 to 27), hospital-related theme (11%; 95% CI, 1 to 21), preference for alternative care (10%; 95% CI, 0 to 21), social influence (7%; 95% CI, 0 to 14), and access-related theme (6%; 95% CI, 0 to 13). The most common factor underlying symptom misinterpretation was mischaracterizing the breast lesion as benign (60%; 95% CI, 4 to 100) which surpassed lack of awareness in the last decade. Misdiagnosis and failure to refer were the dominant hospital-related factors. Modifiable factors such as mischaracterizing malignant masses as benign, fear, misdiagnosis, and failure to refer were the prevalent factors contributing to delays throughout Africa. These factors are promising targets for intervention.

Identifiants

pubmed: 32437263
doi: 10.1200/JGO.19.00402
pmc: PMC7268898
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

731-742

Références

Clin Oncol (R Coll Radiol). 1991 Mar;3(2):78-80
pubmed: 2031886
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Oncol. 2012;2012:121873
pubmed: 22956949
Lancet Glob Health. 2016 Dec;4(12):e923-e935
pubmed: 27855871
East Afr Med J. 2010 Apr;87(4):147-50
pubmed: 23057289
World J Surg Oncol. 2018 Mar 22;16(1):63
pubmed: 29566711
J Glob Oncol. 2017 Mar 8;3(5):497-501
pubmed: 29094088
Breast Care (Basel). 2015 Dec;10(6):364-70
pubmed: 26989354
Asian Pac J Cancer Prev. 2016;17(4):2105-10
pubmed: 27221903
Breast. 2012 Jun;21(3):416-8
pubmed: 22381153
BMC Res Notes. 2012 Aug 21;5:452
pubmed: 22909280
Pan Afr Med J. 2016 May 13;24:63
pubmed: 27642404
BMC Cancer. 2016 Jun 07;16:356
pubmed: 27268201
Br J Cancer. 2012 Mar 27;106(7):1262-7
pubmed: 22415239
Ann Epidemiol. 2017 Oct;27(10):659-671.e7
pubmed: 29128086
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
BMC Cancer. 2018 Mar 21;18(1):312
pubmed: 29562894
Breast Cancer Res Treat. 2017 Feb;162(1):105-114
pubmed: 28025716
Breast Care (Basel). 2018 Mar;13(1):39-43
pubmed: 29950966
J Cancer Epidemiol. 2019 Aug 7;2019:2407138
pubmed: 31485229
Ghana Med J. 2009 Sep;43(3):127-31
pubmed: 20126325
BMC Health Serv Res. 2014 Sep 12;14:387
pubmed: 25217105
Niger J Clin Pract. 2010 Sep;13(3):311-6
pubmed: 20857792
BMJ Open. 2016 Jan 04;6(1):e009905
pubmed: 26729392
J Glob Oncol. 2019 May;5:1-6
pubmed: 31095453
Psychooncology. 2011 May;20(5):532-7
pubmed: 21456061
PLoS One. 2018 Feb 2;13(2):e0192071
pubmed: 29394271
BMJ Open. 2014 Feb 12;4(2):e004076
pubmed: 24523424
BMC Res Notes. 2015 Sep 22;8:467
pubmed: 26395344
Oncologist. 2015 Jul;20(7):780-8
pubmed: 26032138
Cancer. 2008 Oct 15;113(8 Suppl):2244-56
pubmed: 18837017
S Afr J Surg. 2008 Nov;46(4):106-10
pubmed: 19051953
Ethiop J Health Sci. 2015 Oct;25(4):337-44
pubmed: 26949298
Curationis. 2015 Aug 31;38(1):
pubmed: 26841912
Br J Med Med Res. 2014 May 1;4(13):2599-2610
pubmed: 25984460
Int J Cancer. 2018 Apr 15;142(8):1568-1579
pubmed: 29197068
S Afr Med J. 2019 Feb 26;109(3):159-163
pubmed: 30834871

Auteurs

Olayide S Agodirin (OS)

Department of Surgery, University of Ilorin and University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.

Isiaka Aremu (I)

Department of Surgery, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.

Ganiyu A Rahman (GA)

Department of Surgery, University of Cape Coast and Cape Coast Teaching Hospital, Cape Coast, Ghana.

Samuel A Olatoke (SA)

Department of Surgery, University of Ilorin and University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.

Halimat J Akande (HJ)

Department of Radiology, University of Ilorin and University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.

Adetunji S Oguntola (AS)

Department of Surgery, Lautech Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Olalekan Olasehinde (O)

Department of Surgery, Obafemi Awolowo Teaching Hospital, Ile-Ife, Osun State, Nigeria.

Sheriff Ojulari (S)

Department of Physiology, University of Ilorin, Ilorin, Kwara State, Nigeria.

Amarachukwu Etonyeaku (A)

Department of Surgery, Obafemi Awolowo Teaching Hospital, Ile-Ife, Osun State, Nigeria.

Julius Olaogun (J)

Department of Surgery, Ekiti State Teaching Hospital, Ado-Ekiti, Ekiti State, Nigeria.

Anya Romanoff (A)

Breast Surgery, Dubin Breast Center, Icahn School of Medicine, The Mount Sinai Hospital, New York, NY.
Department of Health System Design and Global Health, Icahn School of Medicine, The Mount Sinai Hospital, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH